Skip to content
← stocks-llm New chat

Short squeeze candidates

39 US companies meet all three conditions a short squeeze needs: at least 15% of their shares outstanding sold short, at least 7 days of average volume needed for those shorts to buy back, and a 14-day RSI of at least 55. They are candidates, not predictions.

Price readings from the 2026-08-06 session. Short interest settled 2026-07-15 — a twice-monthly filing, so it moves on its own schedule.

TickerCompanyShort interestDays to cover 14-day RSIMarket capShort interest as ofPrice data as of
RH RH 30.9% 7.39 59.33 $3.6B 2026-07-15 2026-08-06
DDD 3D SYSTEMS CORP 30.1% 16.45 67.22 $520M 2026-07-15 2026-08-06
XRX XEROX HOLDINGS CORP 28.4% 13.95 57.38 $422M 2026-07-15 2026-08-06
REPL REPLIMUNE GROUP INC 28.2% 9.44 63.86 $1.1B 2026-07-15 2026-08-06
STOK STOKE THERAPEUTICS INC 25.2% 20.73 59.83 $2.0B 2026-07-15 2026-08-06
LYFT Lyft 23.6% 9.12 60.37 $6.2B 2026-07-15 2026-08-06
ABEO ABEONA THERAPEUTICS INC 23.2% 8.28 61.25 $393M 2026-07-15 2026-08-06
TWST TWIST BIOSCIENCE CORP 22.7% 9.69 63.98 $6.8B 2026-07-15 2026-08-06
TMDX TRANSMEDICS GROUP INC 22.3% 9.54 58.62 $2.8B 2026-07-15 2026-08-06
RLAY RELAY THERAPEUTICS INC 22.2% 13.38 59.17 $3.8B 2026-07-15 2026-08-06
RHI Robert Half 22.0% 10.10 60.10 $4.2B 2026-07-15 2026-08-06
PALI PALISADE BIO INC 21.3% 9.98 56.56 $363M 2026-07-15 2026-08-06
ORIC ORIC PHARMACEUTICALS INC 21.3% 13.53 63.38 $1.3B 2026-07-15 2026-08-06
SBH SALLY BEAUTY HOLDINGS INC 21.0% 15.06 61.80 $1.5B 2026-07-15 2026-08-06
OMER OMEROS CORP 20.9% 11.85 68.32 $952M 2026-07-15 2026-08-06
EYE NATIONAL VISION HOLDINGS INC 20.8% 8.95 64.99 $1.8B 2026-07-15 2026-08-06
DXC DXC Technology 20.0% 7.17 62.58 $1.8B 2026-07-15 2026-08-06
WGS GENEDX HOLDINGS CORP CLASS A 19.6% 8.43 57.90 $2.1B 2026-07-15 2026-08-06
CERT Certara, Inc. 19.5% 7.81 65.46 $1.2B 2026-07-15 2026-08-06
ZBIO ZENAS BIOPHARMA INC 19.3% 12.46 62.47 $2.0B 2026-07-15 2026-08-06
TNDM TANDEM DIABETES CARE INC 19.1% 8.73 57.93 $1.3B 2026-07-15 2026-08-06
WW WW International, Inc. 18.5% 18.58 59.00 $169M 2026-07-15 2026-08-06
VRDN VIRIDIAN THERAPEUTICS ORS INC 18.4% 9.87 71.90 $2.3B 2026-07-15 2026-08-06
CADL CANDEL THERAPEUTICS INC 17.7% 9.01 61.38 $775M 2026-07-15 2026-08-06
NRIX NURIX THERAPEUTICS INC 17.3% 13.87 68.00 $2.6B 2026-07-15 2026-08-06
IT Gartner 17.2% 8.97 69.95 $12.4B 2026-07-15 2026-08-06
NCNO nCino 16.9% 7.00 61.00 $2.1B 2026-07-15 2026-08-06
CGEM CULLINAN THERAPEUTICS INC 16.7% 15.22 56.20 $1.1B 2026-07-15 2026-08-06
SVRA SAVARA INC 16.7% 20.82 55.32 $1.2B 2026-07-15 2026-08-06
KOD KODIAK SCIENCES INC 16.6% 13.72 62.69 $2.8B 2026-07-15 2026-08-06
PRGO Perrigo 16.5% 7.13 66.02 $1.7B 2026-07-15 2026-08-06
DNTH DIANTHUS THERAPEUTICS INC 16.5% 8.86 59.29 $6.1B 2026-07-15 2026-08-06
TROX TRONOX HOLDINGS PLC 16.1% 11.23 59.38 $1.1B 2026-07-15 2026-08-06
XMAX XMAX INC 15.8% 9.11 64.07 $583M 2026-07-15 2026-08-06
TSHA TAYSHA GENE THERAPIES INC 15.8% 13.34 56.96 $1.8B 2026-07-15 2026-08-06
AVXL ANAVEX LIFE SCIENCES CORP 15.3% 15.60 72.58 $304M 2026-07-15 2026-08-06
JBIO JADE BIOSCIENCES INC 15.3% 7.16 60.09 $1.1B 2026-07-15 2026-08-06
IMNM IMMUNOME INC 15.2% 10.54 71.85 $2.9B 2026-07-15 2026-08-06
PVLA PALVELLA THERAPEUTICS INC 15.1% 9.15 58.22 $2.2B 2026-07-15 2026-08-06

Short interest here is a percent of shares OUTSTANDING. Percent of shares outstanding, computed from the reported FINRA short interest and the company's share count — percent of FLOAT would be higher, because float excludes insider and restricted shares and is not disclosed in the FINRA source.

Every figure describes a position that already exists. Short interest and days to cover come from FINRA's twice-monthly disclosure, published days after it settles; the 14-day RSI beside them is recomputed each night from our own daily closes. That is why each row carries both dates rather than one. Companies whose share count we could not establish are left out entirely rather than shown as lightly shorted, and a company whose price history crosses an unadjusted change is excluded rather than ranked on a reading that change produced. Universe: SEC EDGAR (Russell 3000 + Dow).

Informational only — NOT financial advice. Most heavily shorted stocks never squeeze, a short position can be a hedge rather than a bet against the company, and nothing here predicts that any of these will move.

Research stocks in your own words.

Informational only — NOT financial advice.

ScreenersBlogPrivacyiOS app